Gyre Therapeutics, Inc. ('Gyre”, 'Gyre Therapeutics” or the 'Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today ...
Vertex Pharmaceuticals ended a Phase 1/2 study of an inhaled cystic fibrosis treatment developed jointly with Moderna after the study showed "persistent tolerability issues" with the drug. The ...
A phase 2 trial of Enterprise Therapeutics’ cystic fibrosis (CF) drug candidate has hit its primary endpoint, furthering the ...
Enterprise Therapeutics has reported that its phase 2 trial of ETD001, an investigational inhaled epithelial sodium channel ...
Cystic fibrosis affects nearly 40,000 Americans. Unfortunately, there's no cure. But there is hope, and you can be a part of ...
Leaders with the Cystic Fibrosis Foundation are getting ready for their annual "Great Strides Walk." The walk serves as a way ...
Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver disease and GI oncological therapeutics, today ...
Many liver diseases share a common characteristic: fibrosis, that is, the progressive accumulation of scarring in the liver ...
A cystic fibrosis vest is a therapeutic tool. When worn, it provides compressions similar to manual chest percussions. Wearing the vest can help loosen sticky secretions so that a person can more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results